Principal Scientist, NovaBiotics LTD, UK
I have been a biomedical scientist for over 20 years and have had an interest in antibiotic resistance throughout this period. I currently work for a specialist biotechnology company focused on the development of novel antimicrobials with properties that minimise the risk of the development of resistance, that are effective against antibiotic resistant pathogens and that can reverse existing resistance. I firmly believe that new antimicrobials are urgently needed and that in the future we will have less options to treat infections caused by resistant pathogens. Additionally, I strongly believe that without education and engagement with government, healthcare professionals, industry and other appropriate bodies, that existing antibiotics will continue to be used sub-optimally, and in some cases inappropriately. I believe that Antibiotic Action Champions can help at all levels in developing strategies to extend the life-span of existing antibiotics and in encouraging the development of novel antimicrobials.